FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Furosemide Injection
Status: Currently in Shortage
»Date first posted: 04/07/2020
»Therapeutic Categories: Cardiovascular

Expand all

Athenex Pharmaceutical Division, LLC (Athenex) (Reverified 11/30/2021)

Company Contact Information:
855-273-0154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/2mL vial (NDC 70860-302-41 and 70860-302-02) Available Marketed by Athenex. To order, contact Athenex at 855-273-0154
40 mg/4mL vial (NDC 70860-302-42 and 70860-302-04) Available Marketed by Athenex. To order, contact Athenex at 855-273-0154
100 mg/10mL vial (NDC 70860-302-43 and 70860-302-10) Available Marketed by Athenex. To order, contact Athenex at 855-273-0154

AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.) (Reverified 11/05/2021)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/2 mL single-dose vial (NDC 55150-322-25) Currently on backorder, next shipment TBD Check wholesalers for inventory Delay in shipping of the drug
40 mg/4 mL single-dose vial (NDC 55150-323-25) Available Check wholesalers for inventory Delay in shipping of the drug
100 mg/10 mL single-dose vial (NDC 55150-324-25) Available Check wholesalers for inventory Delay in shipping of the drug

Baxter Healthcare (Reverified 11/23/2021)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Furosemide Injection, USP, 10 mg/mL - 10 mL Single Dose Glass Vial (25 x 10 mL) (NDC 36000-284-25) Available
Furosemide Injection, USP, 10 mg/mL - 2 mL Single Dose Glass Vial (25 x 2 mL)(NDC 36000-282-25) Available
Furosemide Injection, USP, 10 mg/mL - 4 mL Single Dose Glass Vial (25 x 4 mL)(NDC 36000-283-25) Available

Fresenius Kabi USA, LLC (Reverified 11/23/2021)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg per 2 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-02) Available Check wholesalers for inventory. Demand increase for the drug
40 mg per 4 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-04) Backordered. Next release December 2021. Check wholesalers for inventory. Demand increase for the drug
100 mg per 10 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-10) Available Check wholesalers for inventory. Demand increase for the drug

Gland Pharma Limited (Reverified 07/16/2021)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mL in 1 vial, 25 vials/carton (NDC 25021-311-02) Available Marketing partner: Sagent Pharmaceuticals Demand increase for the drug
4 mL in 1 vial, 25 vials/carton (NDC 25021-311-04) Available Marketing partner: Sagent Pharmaceuticals Demand increase for the drug
10 mL in 1 vial, 25 vials/carton (NDC 25021-311-10) Available Marketing partner: Sagent Pharmaceuticals Demand increase for the drug

Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals (Reverified 10/13/2021)

Company Contact Information:
855-228-9470

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/mL (NDC 23155-473-41) Available
40 mg/4mL (NDC 23155-473-42) Available
100 mg/10mL (NDC 23155-473-44) Available

Hospira, Inc. (Revised 11/30/2021)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-02) Limited Supply Available. Next Delivery: February 2022; Estimated Recovery: May 2022 Demand increase for the drug
40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-04) Limited Supply Available. Next Delivery: February 2022; Estimated Recovery: May 2022 Demand increase for the drug
100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial (NDC 0409-6102-10) Available Other
100 mg/10 mL (10 mg/mL; Ansyr Plastic syringe (NDC 0409-1639-10) Limited Supply Available. Demand increase for the drug
40 mg/4 mL (10 mg/mL); Ansyr Plastic syringe (NDC 0409-9631-04) Limited Supply Available. Demand increase for the drug

Sagent Pharmaceuticals (Reverified 10/22/2021)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/2 mL single-dose vial (NDC 25021-311-02) Available
40 mg/4 mL single-dose vial (NDC25021-311-04) Available
100 mg/10 mL single-dose vial (NDC 25021-311-10) Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English